BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, January 3, 2025
See today's BioWorld Asia
Home
» SK Bioscience developing combo flu and COVID-19 vaccine, a first of its kind in South Korea
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
SK Bioscience developing combo flu and COVID-19 vaccine, a first of its kind in South Korea
March 1, 2022
By
Gina Lee
No Comments
SK Bioscience Ltd. is developing a vaccine intended to simultaneously immunize people against the flu and COVID-19.
BioWorld Asia
Infection
Coronavirus
Vaccine
Asia-Pacific
